36.88
0.33%
0.12
前日終値:
$36.76
開ける:
$37.59
24時間の取引高:
6.85M
Relative Volume:
1.52
時価総額:
$75.24B
収益:
$39.71B
当期純損益:
$3.17B
株価収益率:
10.71
EPS:
3.4423
ネットキャッシュフロー:
$6.05B
1週間 パフォーマンス:
-1.71%
1か月 パフォーマンス:
-8.49%
6か月 パフォーマンス:
-13.37%
1年 パフォーマンス:
+6.65%
Gsk Plc Adr Stock (GSK) Company Profile
Gsk Plc Adr Stock (GSK) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-07-08 | ダウングレード | UBS | Buy → Neutral |
2024-05-30 | 開始されました | Goldman | Neutral |
2024-03-04 | アップグレード | Guggenheim | Neutral → Buy |
2024-02-13 | アップグレード | Citigroup | Neutral → Buy |
2024-01-23 | 開始されました | Morgan Stanley | Equal-Weight |
2024-01-16 | 再開されました | UBS | Buy |
2024-01-03 | アップグレード | Jefferies | Hold → Buy |
2023-07-14 | 開始されました | HSBC Securities | Reduce |
2023-03-17 | アップグレード | Deutsche Bank | Hold → Buy |
2023-02-27 | 再開されました | Goldman | Buy |
2023-01-03 | ダウングレード | JP Morgan | Neutral → Underweight |
2022-12-05 | ダウングレード | BofA Securities | Neutral → Underperform |
2022-11-11 | ダウングレード | UBS | Neutral → Sell |
2022-09-15 | アップグレード | Credit Suisse | Underperform → Neutral |
2022-09-08 | ダウングレード | Jefferies | Buy → Hold |
2022-08-05 | 再開されました | Morgan Stanley | Equal-Weight |
2022-07-21 | 再開されました | Citigroup | Neutral |
2022-02-11 | ダウングレード | DZ Bank | Buy → Hold |
2021-11-05 | アップグレード | Barclays | Underweight → Equal Weight |
2021-06-24 | アップグレード | Deutsche Bank | Sell → Hold |
2021-03-23 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2021-02-04 | ダウングレード | Deutsche Bank | Hold → Sell |
2021-01-20 | ダウングレード | Credit Suisse | Neutral → Underperform |
2021-01-15 | 開始されました | Deutsche Bank | Hold |
2020-11-02 | アップグレード | Liberum | Hold → Buy |
2020-09-29 | 開始されました | Berenberg | Buy |
2020-02-12 | ダウングレード | Shore Capital | Hold → Sell |
2020-01-16 | ダウングレード | Barclays | Equal Weight → Underweight |
2019-12-02 | 開始されました | SVB Leerink | Outperform |
2019-11-21 | アップグレード | UBS | Neutral → Buy |
2019-10-11 | アップグレード | Cantor Fitzgerald | Hold → Buy |
2019-09-03 | 再開されました | Citigroup | Neutral |
2019-09-03 | アップグレード | Societe Generale | Sell → Buy |
2019-08-13 | 再開されました | JP Morgan | Neutral |
2019-06-17 | 再開されました | Morgan Stanley | Underweight |
2019-03-08 | ダウングレード | Shore Capital | Buy → Hold |
2019-02-22 | ダウングレード | UBS | Buy → Neutral |
2019-01-14 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
2018-12-11 | 再開されました | Jefferies | Buy |
2018-10-09 | 開始されました | Guggenheim | Neutral |
2018-08-30 | ダウングレード | Liberum | Buy → Hold |
2018-04-04 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
2018-03-22 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
2018-02-09 | アップグレード | Kepler | Reduce → Hold |
すべてを表示
Gsk Plc Adr (GSK) 最新ニュース
GSK Plc ADR (NYSE: GSK) Has Outstanding Potential - Stocks Register
Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak - GlobeNewswire Inc.
What Do Analysts Think About ICICI Bank Ltd. ADR’s (NYSE:IBN) Future? - Stocks Register
Weekly Upgrades and Downgrades - InvestorPlace
GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register
5 Stocks to Buy if You’re Concerned About US Market Valuations - Morningstar
21 Best Healthcare Companies to Invest In - Morningstar
Current share price is - GSK
D-Wave Quantum Inc (QBTS) rating initates by B. Riley Securities - Knox Daily
GSK's Studies On Depemokimab For Nasal Polyps Meet Primary Goals - Barchart
Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.
GSK Plc ADR [GSK] is 5.59% higher this YTD. Is it still time to buy? - The DBT News
What You Didn’t Know About General Motors Company (NYSE: GM) This Week - Stocks Register
GSK’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Before You Invest, Make Sure You Check This ADT Inc (NYSE: ADT) Analysis - Stocks Register
What Are You Thinking About Investing In Medical Properties Trust Inc (NYSE: MPW) Stock? - Stocks Register
Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday - sharewise
Introducing Our Rant Against GSK Plc ADR - US Post News
Balance Sheet Insights: GSK Plc ADR (GSK)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Pilgrim’s Pride Corp. (PPC) receives an Equal-weight rating from Stephens - Knox Daily
Berenberg upgrades Carnival plc ADR (CUK) stock to a Hold - Knox Daily
JP Morgan analysts downgrades an Underweight rating for Organon & Co. (OGN) - Knox Daily
GSK Plc ADR (GSK) gets rating Downgrade from UBS - Knox Daily
GSK Plc ADR (GSK) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine
Precidian to List First ADRhedged Securities in the U.S. on Cboe, Providing Exposure to Individual International Companies with an Embedded Currency Hedge - PR Newswire
Tenet Healthcare Corp. [THC] stock for 1,879,734 USD was sold by Ramsey R. Scott - Knox Daily
Ratio Analysis: Unpacking GSK Plc ADR (GSK)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
GSK Plc ADR [GSK] Insider Activity: An Update for Investors - Knox Daily
GSK Plc ADR (GSK) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Cantor Fitzgerald’s latest rating for AMGN stock - Knox Daily
Nutanix Inc [NTNX] Chief Financial Officer makes an insider sale of 24,316 shares worth 1,430,939. - Knox Daily
GSK’s Stock Market Adventure: 9.44% YTD Growth Amidst Volatility - The InvestChronicle
GSK Shares Experience Decline in Value - Knox Daily
Ratio Revelations: GSK Plc ADR (GSK)’s Financial Metrics in the Spotlight - The Dwinnex
Why GSK (GSK) is a Top Value Stock for the Long-Term - Yahoo Finance Australia
Things To Consider Before You Buy GSK Plc ADR (NYSE: GSK) - Stocks Register
GSK Plc ADR [GSK] Is Currently -0.31 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines - Zacks Investment Research
Behind GSK Plc ADR’s 52-Week Range: Uncovering Opportunities for Investors - The InvestChronicle
Gsk Plc Adr (GSK) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):